TrialBMJ open2024

Impact of aspirin dose according to race in secondary prevention of atherosclerotic cardiovascular disease: a secondary analysis of the ADAPTABLE randomised controlled trial.

Guillaume Marquis-Gravel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.